Canandaigua National Bank & Trust CO Abb Vie Inc. Transaction History

Canandaigua National Bank & Trust CO

$1.04 Billion
Q3 2024

A detailed history of Canandaigua National Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Canandaigua National Bank & Trust CO holds 32,111 shares of ABBV stock, worth $5.39 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

32,111

Previous 32,958 2.57%

Holding current value

$5.39 Million

Previous $5.65 Million 12.19%

% of portfolio

0.61%

Previous 0.62%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$163.84 - $199.33 $138,772 - $168,832	-847 Reduced 2.57%	32,111 $6.34 Million
Q2 2024 Jul 11, 2024	BUY	$154.79 - $180.76 $282,182 - $329,525	1,823 Added 5.86%	32,958 $5.65 Million
Q1 2024 Apr 01, 2024	SELL	$159.82 - $182.1 $158,061 - $180,096	-989 Reduced 3.08%	31,135 $5.67 Million
Q4 2023 Jan 04, 2024	SELL	$137.6 - $154.97 $221,260 - $249,191	-1,608 Reduced 4.77%	32,124 $4.98 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $760,928 - $880,886	5,696 Added 20.32%	33,732 $5.03 Million
Q2 2023 Jul 03, 2023	SELL	$132.51 - $164.9 $58,569 - $72,885	-442 Reduced 1.55%	28,036 $3.78 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $483,865 - $557,242	-3,346 Reduced 10.51%	28,478 $4.54 Million
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $17,350 - $26,305	-269 Reduced 0.84%	31,824 $2.43 Million
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $71,480 - $89,437	-991 Reduced 3.0%	32,093 $2.84 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $119,662 - $143,868	1,900 Added 6.09%	33,084 $2.51 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $16,096 - $20,575	245 Added 0.79%	31,184 $2.27 Million
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $625,219 - $735,852	-8,105 Reduced 20.76%	30,939 $2.49 Million
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $63,836 - $78,728	-820 Reduced 2.06%	39,044 $3.6 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $148,746 - $165,359	1,673 Added 4.38%	39,864 $3.77 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $200,927 - $237,742	2,238 Added 6.22%	38,191 $3.54 Million
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $3.31 Million - $4.43 Million	35,953 New	35,953 $3.4 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Bank & Trust CO with notifications on news.

Account

Canandaigua National Bank & Trust CO Abb Vie Inc. Transaction History